Replies to post #21742 on Seelos Therapeutics Inc (SEELQ)

[value1008]

I guess Dr. Alex Denner likes what he sees with APRI's Vitaros and other pipeline candidates!


SCHEDULE 13D
Item 5. Interest in Securities of the Issuer.

(a) The Reporting Persons may be deemed to beneficially own, in the aggregate, 9,271,757 Shares (including 2,747,252 Shares underlying the Warrants) representing approximately 17.64% of the Issuer's outstanding Shares (based upon (i) the 44,330,006 Shares stated to be outstanding as of February 9, 2015 by the Issuer in the Subscription Agreement, (ii) the 5,494,505 Shares issued to the Sarissa Funds pursuant to the Subscription Agreement, and (iii) the 2,747,252 Shares underlying the Warrants).

(b) For purposes of this Schedule 13D:
Sarissa Domestic has sole voting power and sole dispositive power with regard to 5,627,919 Shares (including 1,667,535 Shares underlying the Warrants). Sarissa Offshore has sole voting power and sole dispositive power with regard to 3,643,838 Shares (including the 1,079,717 Shares underlying the Warrants). Sarissa Capital, as the investment advisor to the Sarissa Funds, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the 9,271,757 Shares (including 2,747,252 Shares underlying the Warrants) held by the Sarissa Funds. By virtue of his position as the Chief Investment Officer of Sarissa Capital and as the managing member of Sarissa Capital’s general partner, Dr. [Alexander] Denner may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the 9,271,757 Shares (including 2,747,252 Shares underlying the Warrants) held by the Sarissa Funds.